Disrupting VE-cadherin Y685 phosphorylation inhibits development of experimental diabetic and prediabetic retinopathy

Yixin Wang1, Hongpeng Huang1, Feng Shao1

  • 1Experimental Pharmacology Mannheim, European Center for Angioscience (ECAS).

Insights

Diabetic retinopathy involves early retinal vascular barrier breakdown. Targeting vascular endothelial cadherin (VE-cadherin) Y685 phosphorylation may protect against this condition and maintain neuronal function.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Diabetic Complications

Background:

  • Diabetic retinopathy (DR) is characterized by early retinal vascular barrier breakdown and pericyte loss, with initiating molecular events poorly understood.
  • Vascular endothelial cadherin (VE-cadherin), crucial for endothelial integrity, is reduced in diabetic/prediabetic mouse retinas, preceding pericyte loss.
  • Nucleoside diphosphate kinase B (NDPKB) deficiency is implicated in DR pathogenesis.

Purpose of the Study:

  • To investigate the role of VE-cadherin phosphorylation in diabetic retinopathy.
  • To identify molecular mechanisms linking high glucose and NDPKB deficiency to endothelial dysfunction.
  • To explore therapeutic strategies targeting VE-cadherin in diabetic retinopathy.

Main Methods:

  • In vitro studies using high glucose (HG) and NDPKB-deficient endothelial cells.
  • VE-cadherin Y685F mutation to prevent phosphorylation.
  • In vivo studies using VE-cadherin Y685F-knockin mice under diabetic/prediabetic conditions.
  • Retinal proteomics analysis.

Main Results:

  • HG and NDPKB deficiency induced VE-cadherin Y685 phosphorylation, internalization, and increased angiopoietin 2 (Ang2) via the hexosamine biosynthesis pathway.
  • VE-cadherin Y685F mutation blocked these effects, preventing endothelial barrier dysfunction and pericyte loss.
  • In vivo, Y685F-knockin mice showed protection against diabetes-induced vascular hyperpermeability, reduced O-GlcNAcylation and Ang2, and preserved neuronal function.
  • Proteomics revealed restoration of neurovascular and mitochondrial pathways in Y685F mice.

Conclusions:

  • VE-cadherin Y685 phosphorylation is a key mediator of high glucose- and NDPKB deficiency-induced retinal vascular damage.
  • Targeting VE-cadherin Y685 phosphorylation presents a promising therapeutic strategy for diabetic and prediabetic retinopathy.
  • Maintaining retinal vascular integrity through this approach can preserve neuronal function.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...